Accel-Rx Portfolio Companies Secure $40 Million Follow-On Funding
KisoJi, SoundBite and Zucara, three of Accel-Rx’s portfolio companies, together raised a total of $40 million CDN in follow-on funding to advance the development and commercialization of their technologies.
New Guide Addresses Procurement Myths to Promote Innovation Adoption in Ontario
The Council of Academic Hospitals of Ontario (CAHO) has published a quick reference guide to help tackle procurement myths to pull innovation into the health system faster.
Investor Spotlights: Amgen and AmorChem - JLABS Toronto
JLABS Meet with.. Series helps build partnerships with Amgen and AmorChem. Amgen is seeking for opportunities in relation to their capabilities in oncology, bone health, nephrology, metabolic disorders, neuroscience, inflammation, cardiovascular, discovery research and technology. AmorChem involves financing research-stage projects for them to reach pre-clinical proof-of-concept in a semi-virtual mode.
Antibe Therapeutics Releases Secondary Endpoint Data for Lead Drug
Toronto’s Antibe Therapeutics released positive secondary endpoint data, conducted in their 244 patients, from the recent Phase 2B Gastrointestinal safety study for its lead drug, ATB-346. These results are consistent with the primary endpoint data, previously released on March 20, 2018.
Reviewing 'Formulating a Non-Dilutive Fundraising Strategy', Part 2 of OBIO's 'Building Your Early-Stage Strategy Toolbox' Event
On the evening of Tuesday, June 26th, David Cayea (COO, PlantForm Corporation) shared how PlantForm had developed a strategy for securing non-dilutive funding, through which they had raised over $6.5M in funding, via grants and research contracts alone.
Government of Canada Announces Stream 4 of the Strategic Innovation Fund
The Government of Canada has announced Stream 4 of the Strategic Innovation Fund and that Statements of Interest will be accepted until August 31, 2018.
Ontario Trade Mission to AdvaMed 2018: The MedTech Conference, September 24-26, 2018
Ontario's Ministry of International Trade is organizing a Trade Mission to AdvaMed 2018: The MedTech Conference, September 24-26, 2018, Pennsylvania Convention Center. This Trade Mission will be able to accommodate a maximum of eight Ontario companies.
Ontario 2018 Rehabilitation & Assistive Device Mission to China
Ontario companies with capabilities in rehabilitation or assistive technology and device that can help China better take care of its disabled and aging population are warmly invited to B2B meetings, site visits and briefing, seminars/forum, and exhibitions of the Canada Pavilion at the 2018 China International Care & Rehabilitation Expo (CRE) in Beijing.
Reviewing OBIO's Building Your Early-Stage Strategy Toolbox
On June 26th, OBIO hosted Building Your Early-Stage Strategy Toolbox featuring sessions on formulating a non-dilutive funding strategy, early-stage business strategies, and preparing investor materials.
Perimeter Medical Appoints New CEO
Perimeter is pleased to announce the appointment of Charles S. Carignan as the New CEO, who has an extensive experience in developing and commercializing innovative OCT based tissue imaging solutions.
Engaging with the FDA: An Insider's Perspective - Reviewing Dr. Yuan's Six Considerations
On June 14th, OBIO hosted Dr. Yuan Fang (VP Regulatory Affairs, Quality and Manufacturing; Focal Healthcare Inc.) who spoke about his perspective on the recent changes at the U.S. Food and Drug Administration (FDA).
Seeking Digital Health Companies for Springboard Health Hub
Springboard is recruiting women-led digital health companies to join their 2018 Health Innovation Hub cohort to help those seeking growth funding accelerate through an inflection point of growth.
CellAegis Completes Patient Enrollment in Trial
CellAegis completed its patient enrollment in a large-scale, UK investigator-sponsored trial to further assess the efficacy of remote ischemic conditioning in reducing clinical events in patients presenting with STEMI in patients receiving treatment in hospital catheterization labs or emergency rooms.
Ontario Announces Trade Mission to RESI Boston, September 2018
Ontario's Ministry of International Trade, is organizing a Trade Mission to the RESI Conference, September 6, 2018, Boston Marriott Copley Place Hotel. This Trade Mission will be able to accommodate a maximum of ten Ontario companies.
How to Develop Commercialization Strategies and Be Ready for Anything: Reviewing Dr. Brian Jahns Keynote
During his lively and highly engaging presentation on June 12, ‘Strategic Marketing & Commercialization Plans for Early Stage Companies,’ Dr. Brian Jahns (Senior VP, Commercial and Business Development at Trillium Therapeutics Inc) discussed approaches for developing strategies and the importance of scenario planning.
OBIO's 'Use It or Lose It: Industry Solutions to Ontario's Commercialization Gap' Report Featured in Research Money
Executives from Ontario’s healthcare sector say they could benefit from a network of early adopter institutions and a capital fund that invests directly in health science companies preparing to commercialize their products and market them globally as they scale their businesses in Canada.
"Dream a Bigger Dream" Presentation by Scott Phillips, CEO, Starfish Medical
If you missed the Medical Device Playbook hosted by StarFish Medical and OBIO, you can still watch Starfish CEO Scott Phillips' presentation titled "Dream a Bigger Dream".
Radialis Medical Wins Pitch Competition
Radialis Medical won the Thunder Bay PITCH competition co-hosted by Northern Ontario Angels (NOA) and the Northern Ontario Innovation Centre (NOIC). Competitors' pitches were made to a panel of angel investors who voted on the best pitch.
Engaging the FDA: An Insider's Perspective
On June 14th, get behind-the-scenes on the recent changes at the FDA and learn more about how regulatory process changes affect your company.
Medical Device Playbook Recap and Photo Gallery
On May 10, 2018, Medical Device Playbook 2018 Toronto, co-hosted by Starfish Medical and OBIO, drew a standing-room only audience of 170 health science industry professionals, from company executives, to QA, regulatory and R&D engineering experts from start-ups, manufacturers, consultancies, regulatory and academic organizations.